Drug profile · INN
metformin hydrochloride, sitagliptin
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
metformin hydrochloride, sitagliptin (METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.
Drug details — metformin hydrochloride, sitagliptin
- US status
- approved
- Class
- —
- Route
- FILM COATED
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
metformin hydrochloride, sitagliptin (METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is metformin hydrochloride, sitagliptin?
metformin hydrochloride, sitagliptin (METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.
What is the brand name for metformin hydrochloride, sitagliptin?
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE is a marketed brand name for metformin hydrochloride, sitagliptin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metformin hydrochloride, sitagliptin?
metformin hydrochloride, sitagliptin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.